Published on
September 29, 2016
- 11:30 GMT
Karyopharm Publishes Preclinical Data in Nature Demonstrating Selinexor’s Potential in KRAS-Mutant Non-Small Cell Lung Cancer (...
- Nuclear Transport Machinery Identified as a Necessary and Universal Driver of KRAS-mutant Cell Survival - - Inhibition of the Nuclear Export Protein XPO1 Promoted Apoptosis across a Panel of Aggressive NSCLCs - NEWTON, Mass., Sept. 29, 2016 (GLOBE …
Distribution channels:
Healthcare & Pharmaceuticals Industry
